Lv3
270 积分 2024-06-27 加入
A CAAR NK cell approach to eliminate pathogenic autoantibody-secreting cells
2天前
已完结
Safety, Tolerability and Efficacy of Narsoplimab, a Novel MASP-2 Inhibitor for the Treatment of IgA Nephropathy
2天前
已完结
Bortezomib plus dexamethasone for rituximab-resistant PLA2R+ membranous nephropathy
3天前
已完结
Daratumumab for multidrug-resistant phospholipase-A2 receptor–related membranous nephropathy
4天前
已完结
Application of CD38 monoclonal antibody in kidney disease
4天前
已完结
Exposure to Chinese famine in early life modifies the association between hyperglycaemia and cardiovascular disease
1个月前
已完结
Bortezomib plus dexamethasone for rituximab-resistant PLA2R+ membranous nephropathy
1个月前
已完结
Daratumumab for multidrug-resistant phospholipase-A2 receptor–related membranous nephropathy
1个月前
已完结
Stem-cell therapy for diabetes: the hope continues
1个月前
已完结
Stem-cell therapy for diabetes: the hope continues
1个月前
已关闭
皖公网安备34019202002308
